Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines

Vanya Shah, Phuong Nguyen, Ngoc Ha Nguyen, Marie Togashi, Thomas (Tom) Scanlan, John D. Baxter, Paul Webb

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

It is desirable to obtain new antagonists for thyroid hormone receptors (TRs) and other nuclear receptors (NRs). We previously used X-ray structural models of TR ligand binding domains (LBDs) to design compounds, such as NH-3, that impair coactivator binding to activation function 2 (AF-2) and block thyroid hormone (triiodothyronine, T3) actions. However, TRs bind DNA and are transcriptionally active without ligand. Thus, NH-3 could modulate TR activity via effects on other coregulator interaction surfaces, such as activation function (AF-1) and corepressor binding sites. Here, we find that NH-3 blocks TR-LBD interactions with coactivators and corepressors and also inhibits activities of AF-1 and AF-2 in transfections. While NH-3 lacks detectable agonist activity at T3-activated genes in GC pituitary cells it nevertheless activates spot 14 (S14) in HTC liver cells with the latter effect accompanied by enhanced histone H4 acetylation and coactivator recruitment at the S14 promoter. Surprisingly, T3 promotes corepressor recruitment to target promoters. NH-3 effects vary; we observe transient recruitment of N-CoR to S14 in GC cells and dismissal and rebinding of N-CoR to the same promoter in HTC cells. We propose that NH-3 will generally behave as an antagonist by blocking AF-1 and AF-2 but that complex effects on coregulator recruitment may result in partial/mixed agonist effects that are independent of blockade of T3 binding in some contexts. These properties could ultimately be utilized in drug design and development of new selective TR modulators.

Original languageEnglish (US)
Pages (from-to)69-77
Number of pages9
JournalMolecular and Cellular Endocrinology
Volume296
Issue number1-2
DOIs
StatePublished - Dec 16 2008

Fingerprint

Hormone Antagonists
Thyroid Hormone Receptors
Genes
Cells
Cell Line
Co-Repressor Proteins
Chemical activation
Triiodothyronine
Ligands
Acetylation
Drug Design
Structural Models
Cytoplasmic and Nuclear Receptors
Thyroid Hormones
Liver
Histones
Modulators
Transfection
Binding Sites
X-Rays

Keywords

  • Antagonist
  • Coactivator
  • Corepressor
  • Thyroid hormone
  • Thyroid hormone receptor

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Biochemistry

Cite this

Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines. / Shah, Vanya; Nguyen, Phuong; Nguyen, Ngoc Ha; Togashi, Marie; Scanlan, Thomas (Tom); Baxter, John D.; Webb, Paul.

In: Molecular and Cellular Endocrinology, Vol. 296, No. 1-2, 16.12.2008, p. 69-77.

Research output: Contribution to journalArticle

Shah, Vanya ; Nguyen, Phuong ; Nguyen, Ngoc Ha ; Togashi, Marie ; Scanlan, Thomas (Tom) ; Baxter, John D. ; Webb, Paul. / Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines. In: Molecular and Cellular Endocrinology. 2008 ; Vol. 296, No. 1-2. pp. 69-77.
@article{b89ebc1a491249fa8a7e43e22fe8d682,
title = "Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines",
abstract = "It is desirable to obtain new antagonists for thyroid hormone receptors (TRs) and other nuclear receptors (NRs). We previously used X-ray structural models of TR ligand binding domains (LBDs) to design compounds, such as NH-3, that impair coactivator binding to activation function 2 (AF-2) and block thyroid hormone (triiodothyronine, T3) actions. However, TRs bind DNA and are transcriptionally active without ligand. Thus, NH-3 could modulate TR activity via effects on other coregulator interaction surfaces, such as activation function (AF-1) and corepressor binding sites. Here, we find that NH-3 blocks TR-LBD interactions with coactivators and corepressors and also inhibits activities of AF-1 and AF-2 in transfections. While NH-3 lacks detectable agonist activity at T3-activated genes in GC pituitary cells it nevertheless activates spot 14 (S14) in HTC liver cells with the latter effect accompanied by enhanced histone H4 acetylation and coactivator recruitment at the S14 promoter. Surprisingly, T3 promotes corepressor recruitment to target promoters. NH-3 effects vary; we observe transient recruitment of N-CoR to S14 in GC cells and dismissal and rebinding of N-CoR to the same promoter in HTC cells. We propose that NH-3 will generally behave as an antagonist by blocking AF-1 and AF-2 but that complex effects on coregulator recruitment may result in partial/mixed agonist effects that are independent of blockade of T3 binding in some contexts. These properties could ultimately be utilized in drug design and development of new selective TR modulators.",
keywords = "Antagonist, Coactivator, Corepressor, Thyroid hormone, Thyroid hormone receptor",
author = "Vanya Shah and Phuong Nguyen and Nguyen, {Ngoc Ha} and Marie Togashi and Scanlan, {Thomas (Tom)} and Baxter, {John D.} and Paul Webb",
year = "2008",
month = "12",
day = "16",
doi = "10.1016/j.mce.2008.09.016",
language = "English (US)",
volume = "296",
pages = "69--77",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines

AU - Shah, Vanya

AU - Nguyen, Phuong

AU - Nguyen, Ngoc Ha

AU - Togashi, Marie

AU - Scanlan, Thomas (Tom)

AU - Baxter, John D.

AU - Webb, Paul

PY - 2008/12/16

Y1 - 2008/12/16

N2 - It is desirable to obtain new antagonists for thyroid hormone receptors (TRs) and other nuclear receptors (NRs). We previously used X-ray structural models of TR ligand binding domains (LBDs) to design compounds, such as NH-3, that impair coactivator binding to activation function 2 (AF-2) and block thyroid hormone (triiodothyronine, T3) actions. However, TRs bind DNA and are transcriptionally active without ligand. Thus, NH-3 could modulate TR activity via effects on other coregulator interaction surfaces, such as activation function (AF-1) and corepressor binding sites. Here, we find that NH-3 blocks TR-LBD interactions with coactivators and corepressors and also inhibits activities of AF-1 and AF-2 in transfections. While NH-3 lacks detectable agonist activity at T3-activated genes in GC pituitary cells it nevertheless activates spot 14 (S14) in HTC liver cells with the latter effect accompanied by enhanced histone H4 acetylation and coactivator recruitment at the S14 promoter. Surprisingly, T3 promotes corepressor recruitment to target promoters. NH-3 effects vary; we observe transient recruitment of N-CoR to S14 in GC cells and dismissal and rebinding of N-CoR to the same promoter in HTC cells. We propose that NH-3 will generally behave as an antagonist by blocking AF-1 and AF-2 but that complex effects on coregulator recruitment may result in partial/mixed agonist effects that are independent of blockade of T3 binding in some contexts. These properties could ultimately be utilized in drug design and development of new selective TR modulators.

AB - It is desirable to obtain new antagonists for thyroid hormone receptors (TRs) and other nuclear receptors (NRs). We previously used X-ray structural models of TR ligand binding domains (LBDs) to design compounds, such as NH-3, that impair coactivator binding to activation function 2 (AF-2) and block thyroid hormone (triiodothyronine, T3) actions. However, TRs bind DNA and are transcriptionally active without ligand. Thus, NH-3 could modulate TR activity via effects on other coregulator interaction surfaces, such as activation function (AF-1) and corepressor binding sites. Here, we find that NH-3 blocks TR-LBD interactions with coactivators and corepressors and also inhibits activities of AF-1 and AF-2 in transfections. While NH-3 lacks detectable agonist activity at T3-activated genes in GC pituitary cells it nevertheless activates spot 14 (S14) in HTC liver cells with the latter effect accompanied by enhanced histone H4 acetylation and coactivator recruitment at the S14 promoter. Surprisingly, T3 promotes corepressor recruitment to target promoters. NH-3 effects vary; we observe transient recruitment of N-CoR to S14 in GC cells and dismissal and rebinding of N-CoR to the same promoter in HTC cells. We propose that NH-3 will generally behave as an antagonist by blocking AF-1 and AF-2 but that complex effects on coregulator recruitment may result in partial/mixed agonist effects that are independent of blockade of T3 binding in some contexts. These properties could ultimately be utilized in drug design and development of new selective TR modulators.

KW - Antagonist

KW - Coactivator

KW - Corepressor

KW - Thyroid hormone

KW - Thyroid hormone receptor

UR - http://www.scopus.com/inward/record.url?scp=56049124540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56049124540&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2008.09.016

DO - 10.1016/j.mce.2008.09.016

M3 - Article

VL - 296

SP - 69

EP - 77

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -